You are here
Home 🌿 Medical Cannabis News 🌿 GW Pharmaceuticals Sativex Trials Disappoint; Signs Deal In Australia 🌿GW Pharmaceuticals Sativex Trials Disappoint; Signs Deal In Australia
Warning message
The subscription service is currently unavailable. Please try again later.GW Pharmaceuticals PLC Tuesday said the remaining two Phase 3 trials for its Sativex product were consistent with the first trial in that Sativex did not meet the primary endpoint, although they did show a "statistically significant improvement" for Sativex compared with a placebo.
Sativex is being investigated for the treatment of pain in patients with advanced cancer who experience inadequate analgesia during optimized chronic opioid therapy.
"In light of the missed primary endpoint in the first trial earlier this year, these additional results are not a surprise. Nevertheless, we are encouraged by data across the trials which consistently show positive outcomes for US patients when analysed as a separate cohort," said GW Chief Executive Justin Gover.
"We believe that this finding may provide important guidance in determining the optimal target patient population for Sativex and look forward to a discussion with the FDA on a potential path forward," Gover...
This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.
420 Intel is Your Source for Marijuana News
420 Intel Canada is your leading news source for the Canadian cannabis industry. Get the latest updates on Canadian cannabis stocks and developments on how Canada continues to be a major player in the worldwide recreational and medical cannabis industry.
420 Intel Canada is the Canadian Industry news outlet that will keep you updated on how these Canadian developments in recreational and medical marijuana will impact the country and the world. Our commitment is to bring you the most important cannabis news stories from across Canada every day of the week.
Marijuana industry news is a constant endeavor with new developments each day. For marijuana news across the True North, 420 Intel Canada promises to bring you quality, Canadian, cannabis industry news.
You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.
Follow us on Instagram
Connect with us on Linkedin